Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Should You Buy Viking Therapeutics Stock While It Trades Below Its $35 Offering Price?

Key PointsViking Therapeutics raised $575 million in a supplementary public offering after positive trial results.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Finance & Markets

Dollar, Euro, Pound Decline Again

The Pakistani rupee (PKR) closed in green against the US Dollar (USD) for the 253rd consecutive day on Friday. PKR … Read More The post Dollar, Euro, Pound Decline Again appeared first on ProPakistani…

More from Friday 2 October →